Viatris, Inc. has voluntarily recalled a specific lot of Xanax XR (ALPRAZolam) 3 mg extended-release tablets due to potential issues with medication release. The affected lot, 8177156, distributed in 60-count bottles, has an expiration date of February 28, 2027. The U.S. Food and Drug Administration (FDA) has classified this as a Class II recall, which suggests that while there may be temporary health effects, serious harm is unlikely. The issue arose from 'failed dissolution specifications,' meaning the tablets may not dissolve and release the medication as intended, potentially affecting its efficacy. Viatris has confirmed that only this specific lot is impacted, and no other batches or generic versions of ALPRAZolam are affected. They emphasized that the risk to patients is negligible and that there have been no reports of adverse reactions related to this lot. Pharmacies and wholesalers have been instructed to return the affected product, but patients are advised that no action is necessary on their part.